| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 6507 | 2019 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 1746 | 2022 |
| EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) AP Maggioni, U Dahlström, G Filippatos, O Chioncel, MC Leiro, J Drozdz, ... European journal of heart failure 15 (7), 808-817, 2013 | 1663* | 2013 |
| Myocardial viability and survival in ischemic left ventricular dysfunction RO Bonow, G Maurer, KL Lee, TA Holly, PF Binkley, P Desvigne-Nickens, ... New England Journal of Medicine 364 (17), 1617-1625, 2011 | 986 | 2011 |
| Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart … AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ... European journal of heart failure 15 (10), 1173-1184, 2013 | 819 | 2013 |
| European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions MG Crespo‐Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... European journal of heart failure 18 (6), 613-625, 2016 | 759 | 2016 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 655 | 2020 |
| Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ... Jama 323 (14), 1353-1368, 2020 | 515 | 2020 |
| A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left … JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ... European journal of heart failure 21 (5), 665-675, 2019 | 360 | 2019 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 264 | 2019 |
| Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up … MG Crespo-Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... Eur J Heart Fail 18 (6), 613-25, 2016 | 228 | 2016 |
| Risk factors of atrial fibrillation following coronary artery bypass grafting a preliminary report M Banach, J Rysz, P Okonski, M Misztal, M Barylski, R Irzmanski, ... Circulation Journal 70 (4), 438-441, 2006 | 204 | 2006 |
| Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. J Rysz, M Banach, A Cialkowska-Rysz, R Stolarek, M Barylski, J Drozdz, ... membranes 2, 3, 2006 | 185 | 2006 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 177 | 2017 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 148 | 2018 |
| Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial SD Solomon, M Vaduganathan, BL Claggett, RA De Boer, D DeMets, ... Heart Failure 10 (3), 184-197, 2022 | 130 | 2022 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 121 | 2020 |
| Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of … M Canepa, E Straburzynska‐Migaj, J Drozdz, C Fernandez‐Vivancos, ... European Journal of Heart Failure 20 (1), 100-110, 2018 | 112 | 2018 |
| Clinical aspects of assessment of endothelial function. JD Kasprzak, M Kłosińska, J Drozdz Pharmacological reports: PR 58, 33-40, 2006 | 110 | 2006 |
| Original articles Heart-type fatty acid binding protein–a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without … Ł Figiel, JD Kasprzak, J Peruga, P Lipiec, J Drożdż, MK Pakuła, ... Polish Heart Journal (Kardiologia Polska) 66 (3), 253-259, 2008 | 105 | 2008 |
